NRM, relapse, and OS. (A) Six-month cumulative incidence of NRM in AAT-treated patients (blue; 10%) and controls (red; 16%). (B) Six-month cumulative incidence of relapse in AAT-treated patients (7%) and controls (18%). (C) Six-month OS in AAT-treated patients (86%) and controls (78%).